Axogen (AXGN) EBIT Margin (2010 - 2026)
Axogen's quarterly EBIT Margin came in at 4.61% in Q1 2026, down 119.0% year-on-year from 24.25% in Q1 2025, and up 71.75% quarter-over-quarter from 16.31% in Q4 2025.
Axogen has reported EBIT Margin for 17 years, with the latest figure at 4.61% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 119.0% year-over-year to 4.61%; the trailing twelve-month figure through Mar 2026 stood at 3.79% (down 359.0% YoY), and the FY2025 full-year result was 3.49%, down 173.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 4.61%, up from 16.31% in the prior quarter.
- The five-year high for EBIT Margin was 4.08% in Q4 2024, with the low at 36.51% in Q1 2022.
- Average EBIT Margin over 5 years is 10.01%, with a median of 9.75% recorded in 2023.
- Year-over-year, EBIT Margin jumped 1720 bps in 2024 and slumped 2040 bps in 2025.
- Tracing AXGN's EBIT Margin over 5 years: stood at 15.51% in 2022, then soared by 52 bps to 7.44% in 2023, then surged by 155 bps to 4.08% in 2024, then sank by 500 bps to 16.31% in 2025, then soared by 72 bps to 4.61% in 2026.
- The last three EBIT Margin figures came in at 4.61% (Q1 2026), 16.31% (Q4 2025), and 3.18% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | -4.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.61% |
| Dec 31, 2025 | -16.31% |
| Sep 30, 2025 | 3.18% |
| Jun 30, 2025 | 2.95% |
| Mar 31, 2025 | -3.42% |
| Dec 31, 2024 | 4.08% |
| Sep 30, 2024 | -0.65% |
| Jun 30, 2024 | -0.89% |
| Mar 31, 2024 | -11.02% |
| Dec 31, 2023 | -7.44% |
| Sep 30, 2023 | -9.75% |
| Jun 30, 2023 | -18.09% |
| Mar 31, 2023 | -20.02% |
| Dec 31, 2022 | -15.51% |
| Sep 30, 2022 | -13.14% |
| Jun 30, 2022 | -23.00% |
| Mar 31, 2022 | -36.51% |
| Dec 31, 2021 | -16.97% |
| Sep 30, 2021 | -21.44% |
| Jun 30, 2021 | -21.30% |
| Mar 31, 2021 | -20.04% |
| Dec 31, 2020 | -16.54% |
| Sep 30, 2020 | -3.13% |
| Jun 30, 2020 | -37.32% |
| Mar 31, 2020 | -35.07% |
| Dec 31, 2019 | -26.34% |
| Sep 30, 2019 | -21.40% |
| Jun 30, 2019 | -28.73% |
| Mar 31, 2019 | -43.82% |
| Dec 31, 2018 | -24.99% |
| Sep 30, 2018 | -21.34% |
| Jun 30, 2018 | -23.41% |
| Mar 31, 2018 | -28.92% |
| Dec 31, 2017 | -10.65% |
| Sep 30, 2017 | -9.34% |
| Jun 30, 2017 | -9.53% |
| Mar 31, 2017 | -26.14% |
| Dec 31, 2016 | -23.84% |
| Sep 30, 2016 | -10.55% |
| Jun 30, 2016 | -15.47% |
| Mar 31, 2016 | -32.33% |
| Dec 31, 2015 | -33.96% |
| Sep 30, 2015 | -23.52% |
| Jun 30, 2015 | -33.55% |
| Mar 31, 2015 | -51.37% |
| Dec 31, 2014 | -56.51% |
| Sep 30, 2014 | -38.60% |
| Jun 30, 2014 | -54.52% |
| Mar 31, 2014 | -95.31% |
| Dec 31, 2013 | -93.72% |
| Sep 30, 2013 | -76.99% |
| Jun 30, 2013 | -76.66% |
| Mar 31, 2013 | -108.43% |
| Dec 31, 2012 | -109.10% |
| Sep 30, 2012 | -103.14% |
| Jun 30, 2012 | -78.85% |
| Mar 31, 2012 | -117.40% |
| Dec 31, 2011 | -146.08% |
| Sep 30, 2011 | -230.23% |
| Jun 30, 2011 | -118.42% |
| Mar 31, 2011 | -80.42% |
| Dec 31, 2010 | -179.12% |
| Sep 30, 2010 | -109.75% |
| Jun 30, 2010 | -10,406.36% |